Curaleaf Holdings (CURLF) Stock Analysis & Winston Score
Curaleaf Holdings is one of the largest cannabis companies in the United States. It grows, processes, and sells marijuana products — including flower, edibles, vapes, and tinctures — under brands like Select and Curaleaf. Its customers are adult recreational users and medical patients, and it sells through its own network of retail dispensaries across more than 20 states. Curaleaf makes money by selling cannabis products directly to consumers through its dispensaries and through wholesale to other retailers. It also has operations in Europe, where it focuses on medical cannabis. The company's scale and multi-state retail footprint give it some competitive advantage, but cannabis remains federally illegal in the U.S., which limits banking access, raises taxes, and blocks the company from listing on major U.S. stock exchanges — it trades on the Canadian Securities Exchange instead. The biggest growth driver would be federal legalization or rescheduling of cannabis, while continued federal restrictions remain the central risk.
Winston Score: 28/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Mixed (9/30)
- Growth: Weak (4/20)
- Cash Flow: Weak (1/10)
- Stability: Mixed (3/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $9.99
Market Cap: $2.6B
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: Other OTC


